Colin Kovacs
Biographic Data
| ID | 7733274 |
|---|---|
| NAME | Colin Kovacs |
| GIVEN NAMES | Colin |
| FAMILY NAME | Kovacs |
| SIGNATURE | KOVACS C |
| AFFILIATIONS | University of Toronto |
| ORCID | 0000-0003-3932-6545 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Uptake of Influenza, Pneumococcal, and Covid-19 Vaccines Among People Living with HIV
Understanding Covid-19 Vaccine Confidence in People Living with HIV
Understanding the roots of Covid-19 vaccine hesitancy in at-risk groups, such as persons living with HIV (PLWH), is of utmost importance. We developed a modified Vaccine Hesitancy Scale (VHS) questionnaire using items from the National Advisory Committee on Immunization Acceptability Matrix. To examine factors associated with receiving COVID-19 vaccine and the link between vaccine attitudes and beliefs with vaccine behavior, PLWH were recruited v…
Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals
Although adherence is an important key to the efficacy of antiretroviral therapy (ART), many people living with HIV (PLWH) fail to maintain optimal levels of ART adherence over time. PLWH with the added burden of Hepatitis C virus (HCV) coinfection possess unique challenges that potentially impact their motivation and ability to adhere to ART. The present investigation sought to (1) compare ART adherence levels among a sample of HIV/HCV-coinfecte…
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy
The long-term safety and efficacy of products used in the correction of HIV-associated facial lipoatrophy (FLA) are largely unknown. The purpose of this study was to describe the long-term efficacy and safety of polyalkylimide gel (PAIG) in the treatment of HIV-associated FLA. In this open-label, randomized, single-center study, 31 HIV-positive individuals (median age 48 years (interquartile ranges (IQR) 45, 55, 97% male) with FLA were randomized…
No prominent works on this page.
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy
The long-term safety and efficacy of products used in the correction of HIV-associated facial lipoatrophy (FLA) are largely unknown. The purpose of this study was to describe the long-term efficacy and safety of polyalkylimide gel (PAIG) in the treatment of HIV-associated FLA. In this open-label, randomized, single-center study, 31 HIV-positive individuals (median age 48 years (interquartile ranges (IQR) 45, 55, 97% male) with FLA were randomized…
Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals
Although adherence is an important key to the efficacy of antiretroviral therapy (ART), many people living with HIV (PLWH) fail to maintain optimal levels of ART adherence over time. PLWH with the added burden of Hepatitis C virus (HCV) coinfection possess unique challenges that potentially impact their motivation and ability to adhere to ART. The present investigation sought to (1) compare ART adherence levels among a sample of HIV/HCV-coinfecte…
Understanding Covid-19 Vaccine Confidence in People Living with HIV
Understanding the roots of Covid-19 vaccine hesitancy in at-risk groups, such as persons living with HIV (PLWH), is of utmost importance. We developed a modified Vaccine Hesitancy Scale (VHS) questionnaire using items from the National Advisory Committee on Immunization Acceptability Matrix. To examine factors associated with receiving COVID-19 vaccine and the link between vaccine attitudes and beliefs with vaccine behavior, PLWH were recruited v…
Uptake of Influenza, Pneumococcal, and Covid-19 Vaccines Among People Living with HIV
Internal Medicine (3 works) · Medicine (3 works) · Confidence interval (2 works) · Health psychology (2 works) · Immunology (2 works) · Logistic regression (2 works) · Psychiatry (2 works) · Public health (2 works) · Vaccination (2 works) · Adverse effect (1 work)